183 related articles for article (PubMed ID: 23609794)
1. Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up.
Elliott C; Frith J; Day CP; Jones DE; Newton JL
Dig Dis Sci; 2013 Aug; 58(8):2383-91. PubMed ID: 23609794
[TBL] [Abstract][Full Text] [Related]
2. Systemic symptoms in non-alcoholic fatty liver disease.
Newton JL
Dig Dis; 2010; 28(1):214-9. PubMed ID: 20460914
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
Younossi Z; Henry L
Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
Siddiqui MS; Charlton M
Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
[TBL] [Abstract][Full Text] [Related]
7. Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.
Newton JL; Pairman J; Wilton K; Jones DE; Day C
Clin Auton Res; 2009 Dec; 19(6):319-26. PubMed ID: 19768633
[TBL] [Abstract][Full Text] [Related]
8. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.
Sanchez-Pareja A; Clément S; Peyrou M; Spahr L; Negro F; Rubbia-Brandt L; Foti M
World J Gastroenterol; 2016 Apr; 22(14):3735-45. PubMed ID: 27076758
[TBL] [Abstract][Full Text] [Related]
10. Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.
Rakha EA; Adamson L; Bell E; Neal K; Ryder SD; Kaye PV; Aithal GP
J Clin Pathol; 2010 Sep; 63(9):790-5. PubMed ID: 20819880
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study.
Baba M; Furuya K; Bandou H; Kasai K; Sadaoka K
BMC Gastroenterol; 2011 Jun; 11():70. PubMed ID: 21669003
[TBL] [Abstract][Full Text] [Related]
12. Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study.
Shaheen AA; Kaplan GG; Sharkey KA; Lethebe BC; Swain MG
Liver Int; 2021 Oct; 41(10):2308-2317. PubMed ID: 34037296
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis and alcohol-related liver disease.
Lackner C; Tiniakos D
J Hepatol; 2019 Feb; 70(2):294-304. PubMed ID: 30658730
[TBL] [Abstract][Full Text] [Related]
14. Genetics of alcoholic and nonalcoholic fatty liver disease.
Anstee QM; Daly AK; Day CP
Semin Liver Dis; 2011 May; 31(2):128-46. PubMed ID: 21538280
[TBL] [Abstract][Full Text] [Related]
15. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
[TBL] [Abstract][Full Text] [Related]
17. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.
Newton JL; Jones DE; Henderson E; Kane L; Wilton K; Burt AD; Day CP
Gut; 2008 Jun; 57(6):807-13. PubMed ID: 18270241
[TBL] [Abstract][Full Text] [Related]
18. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
19. Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.
Frith J; Day CP; Robinson L; Elliott C; Jones DE; Newton JL
J Hepatol; 2010 Jan; 52(1):112-6. PubMed ID: 19897272
[TBL] [Abstract][Full Text] [Related]
20. Pathological features of fatty liver disease.
Yeh MM; Brunt EM
Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
